IPCA Laboratories Logo

IPCA Laboratories

🇮🇳
524494
INE571A01038

IPCA Laboratories, a leading pharmaceutical company headquartered in India, specializes in the development and manufacturing of high-quality generics and active pharmaceutical ingredients (APIs). The company offers a broad spectrum of therapeutic solutions, serving global markets with innovative and affordable medicines.

Next Quarterly Earnings

Friday, November 6, 2026
CW 45
Pre-Market
In 71 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 9, 2026

Stock Price

Frequently asked questions

When will IPCA Laboratories report its next quarterly earnings?

IPCA Laboratories is scheduled to report its next quarterly earnings on 11/06/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did IPCA Laboratories last report quarterly earnings?

IPCA Laboratories last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at 15.84 INR.

How often has IPCA Laboratories beaten expectations?

IPCA Laboratories has beaten analyst EPS estimates in 3 of its last 3 evaluated quarters (beat rate: 100%).

How do I add the IPCA Laboratories earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:₹14.00
Actual:
Q2 2026
Beat
Estimate:₹12.43
Actual:₹15.84
Difference:+₹3.41
Q1 2026
Beat
Estimate:₹10.07
Actual:₹11.80
Difference:+₹1.73
Q4 2025
Beat
Estimate:₹11.66
Actual:₹12.20
Difference:+₹0.54
Q3 2025
Estimate:
Actual:

Earnings statistics

Estimates vs. results

3/3
Quarters above estimates
100%
Beat rate
+16.4%
Avg. EPS surprise

Basis: 3 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
IPCA Laboratories
Ticker Symbol
524494
ISIN
INE571A01038
Country
🇮🇳
India
Sector